Czech Republic joins the Widening process within the EP PerMed call

The Ministry of Health / Agency for Health Research ČR are involved in the so-called. Widening process "Pharmacogenomic strategies for personalised medicine approaches (PGxPM2025)" .

What is the Widening Process?

In the 2nd round of the EP PerMed call, Czech researchers have the opportunity to join a successful project consortium provided that:

bring added value to the project;
the coordinator of the successful project consortium will approve the involvement in the form of a Letter of Intent;
The Ministry of AZV ČR will confirm the availability of funds for this purpose.

Detailed information on the national conditions of participation is available in the document "Conditions for the participation of a Czech applicant in the call", which can be found on the AZV websitePodminky-zapojeni-ceskeho-uchazece-do-PerMed-Call.pdf, starting on page 17.

Where to find successful project consortia after the 1st round of the EP PerMed call?

The platform is open for interested parties B2Matchwhere you can get in touch with coordinators of successful projects looking for new partners from underrepresented countries.More information is also available on the official website EP PerMed.